Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Net Asset Quality Index
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Net Asset Quality Index of 71.5% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $493.25 Million minus total liabilities of $140.71 Million yields net assets of $352.54 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Zhengye Biotechnology Holding Limited Or to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Zhengye Biotechnology Holding Limited Ordinary Shares Net Asset Quality Index Over Time (2021–2025)
This chart shows how Zhengye Biotechnology Holding Limited Ordinary Shares's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2025, the index stands at 71.5%, representing net assets of $352.54 Million against total assets of $493.25 Million USD. See how liquid is Zhengye Biotechnology Holding Limited Or's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ZYBT company net worth.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 71.5% | $352.54 Million | $493.25 Million | $140.71 Million | ▲ +0.0 pp |
| 2024 | 71.5% | $352.54 Million | $493.25 Million | $140.71 Million | ▲ +3.6 pp |
| 2023 | 67.9% | $339.27 Million | $499.89 Million | $160.62 Million | ▼ -0.8 pp |
| 2022 | 68.7% | $356.87 Million | $519.67 Million | $162.81 Million | ▼ -2.9 pp |
| 2021 | 71.6% | $318.84 Million | $445.28 Million | $126.44 Million | — |